SCHEMBL11565658

SCHEMBL11565658

CC(CNc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 17/20 0.71
▸ ADRB1 P08588 15/20 0.71
▸ ADRA1D P25100 7/20 0.71
▸ ADRA1A P35348 7/20 0.71
▸ ADRA1B P35368 7/20 0.71
▸ CYP2D6 P10635 2/20 0.71
▸ ADRA2A P08913 2/20 0.71
▸ KDM4E B2RXH2 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ LMNA P02545 2/20 0.71
▸ HPGD P15428 2/20 0.71
▸ HSD17B10 Q99714 2/20 0.71
▸ HTR1A P08908 1/20 0.71
▸ SLC6A2 P23975 1/20 0.71
▸ SLC6A4 P31645 1/20 0.71
▸ OPRM1 P35372 1/20 0.71
▸ DRD3 P35462 1/20 0.71
▸ HTR2B P41595 1/20 0.71
▸ SLC6A3 Q01959 1/20 0.71
▸ SIGMAR1 Q99720 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11560731 0.91 ADRB2 (0.75) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL11564848 0.88 ADRB2 (0.71) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL11571050 0.87 ADRB1 (0.70) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL7208694 0.85 ADRB2 (0.80) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL7208690 0.85 ADRB2 (0.80) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL10883901 0.85 ADRB2 (0.72) ADRB2ADRB1ADRA1DADRA1AADRA1B
SCHEMBL3719343 0.85 ADRB2 (0.72) ADRB2ADRB1ADRA1DADRA1AADRA1B
Labetalol SCHEMBL10882744 0.83 ADRB1 (1.00) ADRB2ADRB1ADRA1DADRA1AADRA1B
Labetalol SCHEMBL4582 0.83 ADRB1 (1.00) ADRB2ADRB1ADRA1DADRA1AADRA1B
Dilevalol SCHEMBL79468 0.83 ADRB1 (1.00) ADRB2ADRB1ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4163053-A Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides SCHERING CORPORATION (US) 1979-07-31 — — US disclosed
EP-0002867-A1 5-(2-Anilinoalkylamino-1-hydroxyalkyl)salicylamides, their preparation and anti-hypertensive compositions containing them Technobiotic Ltd. (CH) 1979-07-11 — — EP disclosed
Send feedback